Article
http://www.researchprotection.org/sharavTestimonyArmyMedDept020507.htm has moved to:
https://ahrp.org/testimonypresentations/armymeddept.php
Please click on the link above to visit this page, and adjust your bookmarks accordingly.
http://www.researchprotection.org/sharavTestimonyArmyMedDept020507.htm has moved to:
https://ahrp.org/testimonypresentations/armymeddept.php
Please click on the link above to visit this page, and adjust your bookmarks accordingly.
P&G Osteoperosis Drug Trials Spark Major Academic Research Debate Re: Concealed Data Friday, November 25, 2005 Dr. Aubrey Blumsohn: “No self-respecting scientist could ever be expected to publish findings based on data to which they do not have complete and full access.” Sri David Weatherall, Professor Emeritus, Oxford: “People need…
Doctors Without Borders: Why you can’t trust medical journals anymore Tue, 13 Apr 2004 Related link: Hear an interview with Shannon Brownlee on NPR at: http://www.npr.org/features/feature.php?wfId=1874563 Doctors Without Borders in the Washington Monthly (excerpt below), looks at the intricate web of collaborating players in medicine who are financially tied one…
Is it Cloning? U.S. experiment in China – Baltimore Sun Fri, 17 Oct 2003 Concern has been raised about unauthorized US initiated human experiments conducted offshore. One such experiment is said to come “perilously close to human cloning.” The debate prompted the chief scientist of a biotech company in Singapore…
FDA May Require Longer Studies Before Approving Psych Drugs – WSJ Tue, 18 Oct 2005 The Wall Street Journal reports that the FDA has sent out feelers to drug manufacturers to provide “longer-term efficacy data” for psychotropic drugs. This comes after a mountain of evidence shows placebo “works” just as…
From the Los Angeles Times THE NATION Suicide Rate Down in the Era of Prozac Numbers have declined since a 1980s peak when such drugs came into use, a study finds. A skeptic says gun laws might be the cause. By Alan Zarembo Times Staff Writer February 3, 2005 The…
Cholesterol lowering drug, Crestor Linked to Patient Death Tue, 11 Jan 2005 Crestor, a highly advertised cholesterol-lowering drug in the statin class–as was Bayer’s drug Baycol, which was withdrawn from market after 30 patients died of rhabdomyolysis (breakdown of skeletal muscle fibers), has been linked to a patient’s death. “AstraZeneca…